Abstract:In oral delivery of biomacromolecules, ligand-modified nanoparticles (NPs) have emerged as a promising tool to improve the epithelial uptake of the loaded protein/peptide. Unfortunately, the stability and the transport mechanisms of the biotherapeutics during the intracellular transportation still remained unclear, leading to the poor transepithelial efficiency. Additionally, developing novel approaches to simultaneously monitor the payload bioactivity during the transport processes is veritably benefit for keeping their bioactivity. In the present study, EGP peptide (KRKKKGKGLGKKRDPCLRKYK), a ligand with high affinity to heparan sulfate proteoglycans (HSPGs), was found remarkably increasing the cellular uptake (4.5-fold) and also surprisingly achieving high transcytosis efficiency (4.2-fold) of poly(lactide- co-glycolide) NPs on Caco-2 cell monolayer. Compared with unmodified NPs (C NPs), EGP modified NPs (EGP NPs) exhibited more desirable colloidal stability within epithelia. In the subsequent study, the bioactivity of encapsulated insulin during the cellular transportation was innovatively monitored by a glucose consumption assay. Inspiringly, EGP NPs could mostly retain the bioactivity of loaded insulin whereas insulin from INS-C NPs was significantly degraded. Then the detailed mechanism study revealed that the binding of EGP to HSPGs played a vital role on NP transportation. Unlike C NPs being delivered in the endo/lysosomal pathway, EGP NPs were involved in caveolae-mediated transport, which contributes to the efficient avoidance of the lysosomal entrapment and sequentially facilitates the direct apical-to-basolateral transcytosis. The enhanced absorption of EGP NPs was confirmed in in situ intestinal loop models. Most importantly, oral administrated INS-EGP NPs generated a strong hypoglycemic response on diabetic rats with 10.2-fold and 2.6-fold increase in bioavailability compared with free insulin and INS-C NPs, respectively. The work provided an innovative strategy to monitor the payload bioactivity during the transport processes and proposed a novel aspect to increase oral bioavailability of biomacromolecules via improving payload stability and regulating the transcytosis pathway of nanocarriers.

Customizing biomimetic surface attributes of dendritic lipopeptide nanoplatforms for extended circulation

Construction Of Biomimetic Long-Circulation Delivery Platform Encapsulated By Zwitterionic Polymers For Enhanced Penetration Of Blood-Brain Barrier

Long-circulating Polymeric Nanoparticles Bearing a Combinatorial Coating of PEG and Water-Soluble Chitosan.

A Universal Approach to Render Nanomedicine with Biological Identity Derived from Cell Membranes.

Nanocomplex Based on Biocompatible Phospholipids and Albumin for Long-Circulation Applications.

Biomedical Applications of Cell Membrane‐Based Biomimetic Nano‐Delivery System

Preparation and Characterization of Nimodipine-Loaded Nanostructured Lipid Systems for Enhanced Solubility and Bioavailability

Surface-adaptive Zwitterionic Nanoparticles for Prolonged Blood Circulation Time and Enhanced Cellular Uptake in Tumor Cells

A Surface-Adaptive Nanocarrier to Prolong Circulation Time and Enhance Cellular Uptake

Long in Vivo Circulating Nanomicelles Formed by Sharp-Contrast Janus Star Polymers Derived from Β-Cyclodextrin Grafted with Lipids and Polyzwitterions

Simply and Cheaply Prepared Liposomal Membrane for Nanocarriers: High Encapsulation Efficiency Based on Broad Regulation of Surface Charges and Ph-Switchable Performance.

Multifunctional Nanoparticles Enable Efficient Oral Delivery of Biomacromolecules Via Improving Payload Stability and Regulating the Transcytosis Pathway.

Lipid Nanovehicles with Adjustable Surface Properties for Overcoming Multiple Barriers Simultaneously in Oral Administration.

Engineering Stem Cell Derived Biomimetic Vesicles for Versatility and Effective Targeted Delivery

Advances in cell membrane-based biomimetic nanodelivery systems for natural products

Nanocarriers Made of Natural Fatty Acids: Modulation of Their Release Profiles through Photo‐Crosslinking

Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release

Smart surface coating of drug nanoparticles with cross-linkable polyethylene glycol for bio-responsive and highly efficient drug delivery

In vivo biodistribution of mixed shell micelles with tunable hydrophilic/hydrophobic surface.

Lipid‐Centric Design of Plasma Membrane‐Mimicking Nanocarriers for Targeted Chemotherapeutic Delivery

Design of Small Nanoparticles Decorated with Amphiphilic Ligands: Self-Preservation Effect and Translocation into a Plasma Membrane.